What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based…
Continue Reading
An AI-powered tool designed for prostate cancer detection, QP-Prostate by Quibim, has been selected for rollout across seven NHS hospitals in England.
This two-year initiative, announced on July 9, 2025, aims to enhance early diagnosis…
Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its…
Continue Reading
Federated learning (FL) is advancing cancer research by enabling privacy-preserving collaborative training of machine learning (ML) models on diverse, multi-centre data. This systematic review synthesises current knowledge on state-of-the-art FL in oncology, focusing on…
Continue Reading
Former President Joe Biden and his family announced on May 18 that he had been diagnosed with an “more aggressive form” of Stage 4 prostate cancer, which has metastasized to his bones.The diagnosis is…
Continue Reading
What You Should Know:
– Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
– The study…
Continue Reading
BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
New Medicare Study Findings
New research published in JAMA Internal Medicine reveals promising evidence that telehealth services may help reduce unnecessary healthcare spending. The study specifically examined whether telehealth contributes to or decreases the utilization…
Researchers at The Clatterbridge Cancer Centre NHS Foundation Trust in Wirral are using AI to enhance the precision of radiotherapy for prostate cancer.
The PIVOTALboost study, which ran from 2018, recently closed after surveying data…
